Facultad de Ciencias, Instituto de Farmacia, Universidad Austral de Chile, Valdivia 5090000, Chile.
Programa de Doctorado en Bioquímica, Universidad de Chile, Santiago 8380544, Chile.
Molecules. 2021 Nov 25;26(23):7153. doi: 10.3390/molecules26237153.
Broad antibacterial spectrum, high oral bioavailability and excellent tissue penetration combined with safety and few, yet rare, unwanted effects, have made the quinolones class of antimicrobials one of the most used in inpatients and outpatients. Initially discovered during the search for improved chloroquine-derivative molecules with increased anti-malarial activity, today the quinolones, intended as antimicrobials, comprehend four generations that progressively have been extending antimicrobial spectrum and clinical use. The quinolone class of antimicrobials exerts its antimicrobial actions through inhibiting DNA gyrase and Topoisomerase IV that in turn inhibits synthesis of DNA and RNA. Good distribution through different tissues and organs to treat Gram-positive and Gram-negative bacteria have made quinolones a good choice to treat disease in both humans and animals. The extensive use of quinolones, in both human health and in the veterinary field, has induced a rise of resistance and menace with leaving the quinolones family ineffective to treat infections. This review revises the evolution of quinolones structures, biological activity, and the clinical importance of this evolving family. Next, updated information regarding the mechanism of antimicrobial activity is revised. The veterinary use of quinolones in animal productions is also considered for its environmental role in spreading resistance. Finally, considerations for the use of quinolones in human and veterinary medicine are discussed.
广谱抗菌活性、高口服生物利用度和优异的组织穿透性,再加上安全性和较少的、但罕见的不良反应,使喹诺酮类抗菌药物成为住院患者和门诊患者最常用的药物之一。喹诺酮类最初是在寻找具有增强抗疟活性的改良氯喹衍生物分子时发现的,如今,作为抗菌药物的喹诺酮类包括四代,它们逐渐扩大了抗菌谱和临床应用。喹诺酮类抗菌药物通过抑制 DNA 回旋酶和拓扑异构酶 IV 发挥其抗菌作用,进而抑制 DNA 和 RNA 的合成。良好的分布于不同组织和器官,用于治疗革兰氏阳性和革兰氏阴性细菌,使喹诺酮类成为治疗人类和动物疾病的首选药物。喹诺酮类在人类健康和兽医领域的广泛应用导致了耐药性的上升和威胁,使喹诺酮类家族无法有效治疗感染。本综述回顾了喹诺酮类结构、生物学活性的演变以及该不断发展的家族的临床重要性。接下来,还对抗菌活性的作用机制进行了更新。还考虑了喹诺酮类在动物生产中的兽医用途,因为它在传播耐药性方面具有环境作用。最后,讨论了在人类和兽医医学中使用喹诺酮类的问题。